Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Sativex on blood leukocytes in indolent lymphoma and chronic lymphocytic leukemia
2014-005553-39Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol in mantle cell lymphoma (MCL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), follicular lymphoma (FL) and 1 more, sponsored by Karolinska University Hospital. Primary endpoint: Absolute lymphocyte count in peripheral blood. Started May 2015; status: completed.
02
Drugs
cannabidiol
03
Conditions
mantle cell lymphoma (MCL)chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)follicular lymphoma (FL)lymphoma
Beyond the preview
Go deeper on 2014-005553-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005553-39.